Company Overview
| Stock Name | Qianhai Health |
|---|---|
| Stock Code | 00911 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 主要從事採購及批發未經加工處理西洋參業務,包括種植參及野山參,亦銷售經加工處理西洋參及其他產品,客戶主要為二級批發商及零售商,並在香港經營零售門市及店中店專營店。 |
| Listing Date | 2014-06-27 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港上環永樂街177-183號永德商業中心3樓301-303室 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | hangfatg.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 1.98 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | RMB 0.01 / shares |
| Offer Period | To be extracted |
| Global Offering Shares | 500,000,000 shares |
| HK Public Offer Shares (Initial) | 50,000,000 shares (10.0%) |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | 450,000,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 2,000,000,000 shares |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | To be extracted |
| Cornerstone Share | No cornerstone investors |
| Clawback Tiers | To be extracted |
| Reallocation Option | No |
| Total Global Offering Size | HK$ 990,000,000 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| Avg Daily HK Mkt Cap | HK$ 74.1M |
| Est. Threshold | HK$ 9.71B |
| Analysis Result | HK market cap below threshold, need +13004% |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 盈利約128.6百萬港元 |
| Period-End Cash Balance | 47.4百萬港元 |
| Listing Expenses | ~HK$ 63,800,000 |
| Listing Expenses / Funds Raised | ~6.44% |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
HKD
Income Statement
| Item | 2011 | 2012 | 2013 |
|---|---|---|---|
| Revenue | 446,380 | 492,276 | 762,970 |
| Cost of sales | -358,224 | -411,880 | -583,546 |
| Gross profit | 88,156 | 80,396 | 179,424 |
| Other income and gains, net | 2,902 | 2,161 | 1,926 |
| Administrative expenses | -25,749 | -19,123 | -23,616 |
| Net finance costs | -17,080 | -15,768 | -10,999 |
| Profit before tax | 58,054 | 60,770 | 152,939 |
| Income tax expense | -13,645 | -28,428 | -24,326 |
| Profit attributable to owners | 44,409 | 32,342 | 128,613 |
Balance Sheet
| Item | 2011 | 2012 | 2013 |
|---|---|---|---|
| Cash and cash equivalents | 17,756 | 14,245 | 47,368 |
| Trade and bills receivables | 135,180 | 79,572 | 86,942 |
| Inventories | 132,419 | 324,822 | 563,718 |
| Total current assets | 500,618 | 608,205 | 907,973 |
| Total current liabilities | 644,007 | 583,746 | 759,307 |
| Total equity | 189,042 | 113,586 | 242,200 |
| Equity attributable to owners | 189,042 | 113,586 | 242,200 |
| Interest-bearing borrowings | 517,901 | 342,822 | 361,717 |
Cash Flow Statement
| Item | 2011 | 2012 | 2013 |
|---|---|---|---|
| Net cash from operating activities | 175,276 | 4,786 | 48,081 |
| Net cash from investing activities | -154,621 | 87,156 | -21,900 |
| Net cash from financing activities | -6,226 | -95,925 | 6,865 |
| Net increase in cash | 14,429 | -3,983 | 33,046 |
| Depreciation of PP&E | 3,951 | 2,584 | 1,999 |
| Purchase of PP&E | -5,827 | -157 | -1,287 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 1.5 |
|---|---|
| First Day Open | HK$ 1.48 |
| First Day Change | -24.24% |
| First Day Volume | 413008000.0 |
| First Day Turnover | 646165000.0 |
| Use of Proceeds | 1、約648,50萬港元(或募集資金凈額的70%) 用作提高本集團的購買能力,及擴大于種植參及野山參批發市場的市場份額。根據現時市場供求,董事估計約648,50萬港元中,約90%將用于購買種植參,及約10%用于購買野山參,全部均將向客戶銷售;
2、約157,50萬港元(或募集資金凈額的17%) 用作償還若干銀行貸款,該等貸款全部均用作營運資金,借貸利率介乎2.22%至6%,并于二零零九年七月或之后提取,且于二零一九年二月之前到期;
3、約2780萬港元(或募集資金凈額的3%) 用作宣傳及推銷本集團旗下的恒發品牌及通過設立店中店專營店擴充零售業務,藉以擴展本集團的零售業務部,及招聘銷售人員管理本集團的店中店專營店;
4、約9270萬港元(或募集資金凈額的10%) 用作一般營運資金及其他一般企業用途。 |
Underwriting Syndicate
Sole Sponsor (1)
招银国际融资有限公司 CE AVM940
Overall Coordinators (1)
招银国际融资有限公司 CE AVM940
Joint Lead Managers (2)
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 楊永仁 | — |
| Company Secretary | 葉德容 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 楊永仁先生通過Cervera及Athena Power持有約69.45%股份;Cervera持有60%,Athena Power持有9.45%;黃美娟女士(楊永仁先生配偶)持有配偶權益69.45%。 |
|---|




